AbbVie sues drug cost savings company over alleged fraudulent use of patient assistance program
AbbVie sued drug cost savings company Payer Matrix in federal court last week, alleging that the company is operating a “fraudulent and deceptive scheme” and taking advantage of AbbVie’s patient assistance program.
AbbVie alleged that Payer Matrix has been enrolling insured patients into its myAbbVie Assist Patient Assistance Program (PAP) who aren’t truly eligible, according to a complaint filed in the US District Court for the Northern District of Illinois Eastern Division. The pharma giant claimed the company knows that the program is only for uninsured or underinsured patients but enrolls its clients anyway, including those who should be getting medicine through employer insurance plans.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.